Found this mention of oniomania, purported new entrants into DSM-V. Said article has the following tempting title: “Getting the Id to Go Shopping: Psychoanalysis, Advertising, Barbie Dolls, and the Invention of the Consumer Unconscious.” The digest version is:
- Big Pharma creates both supply and demand. Once a diagnosis is in the DSM marketing can begin in earnest.
- Research on oinomania funded by Forest Laboratories, Inc.
- That research found drugs they manufacture, Celexa and Lexapro, were pharmaceutical “cure” for oinomania.
- No mention of potential sources of shopping mania, finding a meaning. That would be the realm of talk therapy.
Here’s some of the text:
Following the news that oniomania, otherwise known as compulsive spending or shopaholism, will be recognized as a clinical disorder in the next diagnostic manual of the American Psychiatric Association, watchdogs of the mind-control industries have been quick to note the “coincidence” that a Stanford University research team’s recent discovery of a pharmaceutical “cure” for oniomania was funded by a pharmaceutical company. Compulsive shoppers, it seems, will be encouraged to make one more purchase: a daily pill to make it all better.
